Showing 1 - 2 results of 2 for search 'Jan Rohr', query time: 0.01s
Refine Results
-
1
-
2
Efficacy, pharmacokinetics and safety of iscalimab (CFZ533) in patients with proliferative lupus nephritis: a randomised, double-blind, placebo-controlled, phase II study by Renaud Felten, Nan Shen, Julia Weinmann-Menke, Ana Malvar, Peter Gergely, Tamas Shisha, Carole Sips, André Serra-Roma, Markus Weiss, Rambabu Danekula, Jan Rohr
Published 2025-08-01Get full text
Article